{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:35:04Z","timestamp":1791164104836,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.autrev.2009.08.001","type":"journal-article","created":{"date-parts":[[2009,8,10]],"date-time":"2009-08-10T09:15:37Z","timestamp":1249895737000},"page":"224-228","source":"Crossref","is-referenced-by-count":36,"title":["B cell-targeted therapies in Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"9","author":[{"given":"Gabriel J.","family":"Tob\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques Olivier","family":"Pers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Youinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Saraux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2009.08.001_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clin.1994.1123","article-title":"Sj\u00f6gren's syndrome: autoimmune epithelitis","volume":"72","author":"Moutsopoulos","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2009.08.001_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.berh.2007.09.001","article-title":"Update on Sj\u00f6gren's syndrome autoimmune epithelitis: from classification to increased neoplasias","volume":"21","author":"Tzioufas","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2009.08.001_bib3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome. A revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2009.08.001_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.berh.2004.03.007","article-title":"Laboratory testing in autoimmune rheumatic diseases","volume":"18","author":"Sheldon","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2009.08.001_bib5","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sj\u00f6gren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sj\u00f6gren's Syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.08.001_bib6","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/art.10445","article-title":"Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sj\u00f6gren's syndrome","volume":"46","author":"Hansen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.08.001_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2007.01.010","article-title":"Polarization of B effector cells in Sj\u00f6gren's syndrome","volume":"6","author":"Daridon","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.08.001_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.autrev.2006.09.011","article-title":"The mosaic of B-cell subsets (with special emphasis on primary Sj\u00f6gren's syndrome)","volume":"6","author":"Le Pottier","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.08.001_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.revmed.2008.01.018","article-title":"B lymphocytes in Sj\u00f6gren's syndrome","volume":"29","author":"Pers","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2009.08.001_bib10","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.4049\/jimmunol.0803588","article-title":"Ectopic germinal centers are rare in Sj\u00f6gren's syndrome salivary glands and do not exclude autoreactive B cells","volume":"15","author":"Le Pottier","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2009.08.001_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/art.21478","article-title":"BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjogren's syndrome","volume":"54","author":"d'Arbonneau","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.08.001_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sj\u00f6gren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2009.08.001_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","article-title":"BAFF overexpression is associated with autoantibody production in autoimmune diseases","volume":"1050","author":"Pers","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.autrev.2009.08.001_bib14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/ard.2008.096172","article-title":"Is the blood B-cell subset profile diagnostic for Sj\u00f6gren's syndrome","volume":"68","author":"Binard","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2009.08.001_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/j.1460-2075.1988.tb02867.x","article-title":"Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains","volume":"7","author":"Einfeld","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2009.08.001_bib16","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1016\/S0021-9258(18)60461-2","article-title":"Phosphorylation of the CD20 phosphoprotein in resting B lymphocytes. Regulation by protein kinase C","volume":"264","author":"Valentine","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2009.08.001_bib17","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V63.6.1424.1424","article-title":"Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation","volume":"63","author":"Anderson","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2009.08.001_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4049\/jimmunol.135.2.973","article-title":"The B cell surface molecule B1 is functionally linked with B cell activation and differentiation","volume":"135","author":"Tedder","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2009.08.001_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0167-5699(94)90276-3","article-title":"CD20: a regulator of cell-cycle progression of B lymphocytes","volume":"15","author":"Tedder","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2009.08.001_bib20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.V69.2.584.584","article-title":"Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas","volume":"69","author":"Press","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2009.08.001_bib21","doi-asserted-by":"crossref","first-page":"47:19","DOI":"10.4049\/jimmunol.150.11.4719","article-title":"The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils and monocytes","volume":"150","author":"Engel","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2009.08.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(05)88001-0","article-title":"CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction","volume":"88","author":"Tedder","year":"2005","journal-title":"Adv Immunol"},{"key":"10.1016\/j.autrev.2009.08.001_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1074-7613(00)80270-8","article-title":"CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice","volume":"5","author":"Sato","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2009.08.001_bib24","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.189.8.1307","article-title":"Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies","volume":"189","author":"O'Keefe","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.08.001_bib25","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.08.001_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","article-title":"BAFF: a fundamental survival factor for B cells","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2009.08.001_bib27","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.08.001_bib28","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2009.08.001_bib29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1600-6143.2004.00454.x","article-title":"Rituximab as treatment for refractory kidney transplant rejection","volume":"4","author":"Becker","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.autrev.2009.08.001_bib30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","article-title":"Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2009.08.001_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sj\u00f6gren's syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2009.08.001_bib32","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sj\u00f6gren's syndrome","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.08.001_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8028-z","article-title":"Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases?","volume":"34","author":"Galarza","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2009.08.001_bib34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.22536","article-title":"Improvement of Sj\u00f6gren's syndrome after two infusions of rituximab (Anti-CD20)","volume":"57","author":"Devauchelle-Pensec","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.08.001_bib35","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/art.22603","article-title":"BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sj\u00f6gren's syndrome","volume":"56","author":"Pers","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.08.001_bib36","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.22458","article-title":"Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sj\u00f6gren's syndrome","volume":"56","author":"Daridon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.08.001_bib37","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2007.083865","article-title":"Reduction of fatigue in Sj\u00f6gren syndrome with rituximab: results of a randomized, double-blind, placebo controlled pilot study","volume":"67","author":"Dass","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2009.08.001_bib38","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar2018","article-title":"Epratuzumab (humanized anti-CD22 antibody) in primary Sj\u00f6gren's syndrome: an open-label phase I\/II study","volume":"8","author":"Steinfeld","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2009.08.001_bib39","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar2506","article-title":"Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus","volume":"10","author":"Furie","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2009.08.001_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.autrev.2008.11.006","article-title":"Use of rituximab in patients with systemic lupus erythematosus: an update","volume":"8","author":"Garc\u00eda-Carrasco","year":"2009","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209001426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209001426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T08:42:12Z","timestamp":1685090532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997209001426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1568997209001426"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2009.08.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}